Happy Invivyd-versary to Yuhong Zeng, Gabriel Green-Lemons BS, PharmD, RPh, and Jourdan Hourican, MB(ASCP)! Thank you for all you do to make Invivyd a great place to work. We are lucky to have each of you as part of the team! #weareinvivyd
Invivyd
生物技术研究
Waltham,Massachusetts 11,711 位关注者
Devoted to delivering protection from serious viral infectious diseases.
关于我们
Invivyd, Inc. (Nasdaq: IVVD) is a commercial-stage company is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases. Leveraging state-of-the-art viral surveillance, predictive modeling, and advanced antibody engineering techniques, we are taking a platform-based approach to the continuous discovery and optimization of monoclonal antibody candidates designed to protect the vulnerable from serious viral threats. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for its first mAb in a planned series of innovative antibody candidates. Visit https://invivyd.com/ to learn more.
- 网站
-
https://www.invivyd.com
Invivyd的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- Waltham,Massachusetts
- 类型
- 上市公司
- 创立
- 2020
地点
-
主要
1601 Trapelo Rd
Suite 178
US,Massachusetts,Waltham,02451
Invivyd员工
动态
-
Meet Jason Smith, MBA, Director, Brand Marketing. He shares why he chose Invivyd and why he stays.
-
That's a wrap on Open Enrollment! At Invivyd, we are proud to provide quality benefits that are affordable to our employees and their families, meet the needs of the workforce, and are competitive within our industry. Visit our website to learn more about the benefits we offer: https://lnkd.in/edw2ghUr
-
We are thrilled to welcome Rachael Gerlach, PhD, MPH to the Invivyd team as our new Vice President, Regulatory Affairs.?
-
Invivyd is hiring across the country for Strategic Account Managers and Key Account Managers!?If you’re passionate about protecting vulnerable people from the devastating consequences of circulating viral threats then check out our open positions!?https://lnkd.in/edw2ghUr
-
Invivyd转发了
Immunocompromised Association wants to celebrate and thank Invivyd for their sponsorship! Invivyd is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases.? ? We appreciate getting to know the people behind Invivyd and look forward to great teams working together for the benefit of the immunocompromised community. ? You can learn more about Invivyd at: https://invivyd.com/
-
We are thrilled to announce The New England Journal of Medicine published a peer-reviewed Letter to the Editor detailing the use of an immunobridging approach for emergency use authorization (EUA) of pemivibart. https://lnkd.in/gqQZwexM
-
Join us on Thursday, November 14th at 8:30 AM ET for our earnings conference call where we will discuss our Q3 2024 financial results and recent business highlights. https://lnkd.in/ebMb-ZBw
-
This afternoon, Invivyd's Chief Financial Officer William Duke will participate in a fireside chat at the Guggenheim Healthcare Innovation Conference. Tune in live, or catch a replay on our website to learn more about the exciting progress we are making to advance our mission of delivering protection from serious viral infectious diseases.?https://lnkd.in/ebMb-ZBw
-
During National Nurse Practitioner Week, we are not only thankful for the nurse practitioners that take extraordinary care of vulnerable populations every day, but also for Invivyd's own nurse practitioner Jill Langer, MSN, FNP-BC, Regional Clinic Specialist, who creates meaningful impact within the treatment and diagnostic communities as well as advocacy groups as she supports Invivyd's mission to deliver protection from serious viral infections. #nationalnursepractionerweek #NP #nursepractioner